The Research Institute of the McGill University Health Centre (RI-MUHC) will lead an innovative pan-Canadian network named CHILD-BRIGHT that aims to improve life outcomes for children with brain-based development disabilities and their families. The newly created network is one of five nationwide projects that are being funded by the Canadian Institute of Health Research (CIHR) under their initiative Canada’s Strategy for Patient Oriented Research (SPOR). Each network received a $12.5M grant over five years from the CIHR that was equally matched by other funding partners.
Read more ►
On March 24, 2016, McGill’s Faculty of Medicine celebrated the 2015 winners of the Maube Abbott, Haile T. Debas and Rosemary Wedderburn Brown Prizes, Dr. Amira El-Messidi, Dr. Madhukar Pai and Dr. Philippe Archambault. During the event held in Holmes Hall each laureate had the opportunity to provide a brief overview of their research and personal journey after having been presented with their award by Dr. David Eidelman, Vice-Principal (Health Affairs) and Dean of the Faculty of Medicine. Congratulations to the three laureates!
Read more ►
Fifty Montreal-area high school students put their neurons and synapses to work on March 15 answering questions on … neurons and synapses. The students were contestants in the Brain Bee, a day of neuroscience trivia and learning at the Montreal Neurological Institute and Hospital.
Read more ►
Read More Posts From This Section »
The diabetes drug pioglitazone is associated with an increased risk of bladder cancer, finds a study led by Dr. Laurent Azoulay, an epidemiologist at the Lady Davis Institute at the Jewish General Hospital and Associate Professor of Oncology at McGill University. The findings, published in The BMJ, suggest that the risk grows with increasing duration of use and dose. At the same time, no increased risk was seen for the similar drug rosiglitazone.
Read more ►
For each additional month of paid maternity leave offered in low- and middle-income countries (LMICs), infant mortality is reduced by 13%, according to a new study by researchers from McGill University and UCLA Fielding School of Public Health.
Read more ►
Incretin-based drugs, a type of medication used to treat type 2 diabetes, do not increase the risk of being hospitalized for heart failure relative to commonly used combinations of oral anti-diabetic drugs, according to a new study published in the New England Journal of Medicine.
Read more ►
Read More Posts From This Section »
Dr. Mark Wainberg, Professor of Medicine and Microbiology and Immunology at McGill University and Director of the McGill University AIDS Centre, was presented with the 2016 Association of Medical Microbiology and Infectious Disease Canada (AMMI) Lifetime Achievement Award in recognition of his outstanding and distinguished career during the Association’s annual conference held March 30-April 2 in Vancouver. Congratulations Dr. Wainberg!
Read more ►
On Saturday, March 19, medical students Carl White Ulysse from the Class of 2016, Neil Verma from the Class of 2017 and Doulia Hamad from the Class of 2018 each were presented with a Scarlet Key Award for Leadership during a ceremony held by the Scarlet Key Society. Congratulations to all three!
Read more ►
Read More Posts From This Section »
For the second year in a row, McGill will be organizing activities around World Voice Day. The organization of the free voice screenings (April 8 from 2 – 5:30 in the Strathcona Music Building) and seminar (April 16 from 3-5 in the Elizabeth Wirth Music Building) was led this year by Jenna Hotton, Tara Casorso, Curtis Fischer and Sara Lakhdar, four second-year master’s students in speech-language pathology at the Faculty of Medicine’s School of Communication Science Disorders (SCSD), under the tutelage of Dr. Nicole Li-Jessen, Assistant Professor in the SCSD, and in collaboration with Dr. Isabelle Cossette from the Schulich School of Music and the Centre for Interdisciplinary Research in Music, Media and Technology.
Read more ►
Read More Posts From This Section »